457 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 10 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

HTR1A5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupledDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
HTR1D5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
HTR1F5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
HTR2A5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
HTR2B5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
HTR45-hydroxytryptamine (serotonin) receptor 4, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
HTR75-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
RAS pathway related proteins
Group enriched
ICAM1Intercellular adhesion molecule 1Cancer-related genes
Candidate cardiovascular disease genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IDEInsulin-degrading enzymeEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
IFNGInterferon, gammaCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
IKBKBInhibitor of kappa light polypeptide gene enhancer in B-cells, kinase betaDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
IMPDH1IMP (inosine 5'-monophosphate) dehydrogenase 1Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
IMPDH2IMP (inosine 5'-monophosphate) dehydrogenase 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
ITGA2BIntegrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)Cancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
ITGB3Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
JAK1Janus kinase 1Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
JAK2Janus kinase 2Cancer-related genes
Cytoskeleton related proteins
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
JAK3Janus kinase 3Cancer-related genes
Cytoskeleton related proteins
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Tissue enhanced
JUNJun proto-oncogeneCancer-related genes
FDA approved drug targets
Predicted intracellular proteins
Transcription factors
Expressed in all
KCNA1Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia)Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNA10Potassium voltage-gated channel, shaker-related subfamily, member 10FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNA2Potassium voltage-gated channel, shaker-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNA3Potassium voltage-gated channel, shaker-related subfamily, member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA4Potassium voltage-gated channel, shaker-related subfamily, member 4FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNA5Potassium voltage-gated channel, shaker-related subfamily, member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNA6Potassium voltage-gated channel, shaker-related subfamily, member 6FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNB1Potassium voltage-gated channel, Shab-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNC1Potassium voltage-gated channel, Shaw-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNC2Potassium voltage-gated channel, Shaw-related subfamily, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNC3Potassium voltage-gated channel, Shaw-related subfamily, member 3Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCND1Potassium voltage-gated channel, Shal-related subfamily, member 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Mixed
KCND2Potassium voltage-gated channel, Shal-related subfamily, member 2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium voltage-gated channel, Shal-related subfamily, member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNH2Potassium voltage-gated channel, subfamily H (eag-related), member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ1Potassium inwardly-rectifying channel, subfamily J, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ11Potassium inwardly-rectifying channel, subfamily J, member 11Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNJ12Potassium inwardly-rectifying channel, subfamily J, member 12FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNJ8Potassium inwardly-rectifying channel, subfamily J, member 8Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNK2Potassium channel, subfamily K, member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNK3Potassium channel, subfamily K, member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNK9Potassium channel, subfamily K, member 9Disease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
KCNMA1Potassium large conductance calcium-activated channel, subfamily M, alpha member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNN4Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium voltage-gated channel, KQT-like subfamily, member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium voltage-gated channel, KQT-like subfamily, member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KDRKinase insert domain receptor (a type III receptor tyrosine kinase)Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Tissue enhanced
KEAP1Kelch-like ECH-associated protein 1Cancer-related genes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
KITV-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homologCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Mixed
LCKLCK proto-oncogene, Src family tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Tissue enhanced
LHCGRLuteinizing hormone/choriogonadotropin receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced

« prev | Page of 10 | next »